ARCHIVED - Evaluation of The Prion Diseases Program

Prepared by TDV Global Inc for Public Health Agency of Canada

Table of Contents

• Management Response and Action Plan
• EXECUTIVE SUMMARY
• LIST OF ACRONYMS AND ABBREVIATIONS
• 1.0 INTRODUCTION AND CONTEXT
  • 1.1 Program Description
  • 1.2 Previous Health Canada Evaluation
  • 1.3 Structure of the Report
• 2.0 EVALUATION METHODOLOGY
  • 2.1 Evaluation Framework
  • 2.2 Data Collection through Multiple Lines of Evidence
  • 2.3 Data Quality and Limitations of the Evaluation
• 3.0 RELEVANCE
  • 3.1 Vision
  • 3.2 Mandate
  • 3.3 Consistency
  • 3.4 Continued Need for the Program
• 4.0 SUCCESS
  • 4.1 Expected Outputs
  • 4.2 Outcomes
  • 4.3 Unexpected Outcomes
• 5.0 DESIGN AND DELIVERY
  • 5.1 Management Structures
  • 5.2 Partnerships
  • 5.3 Lessons Learned
  • 5.4 Resourcing
  • 5.5 Alternate Delivery Systems
• 6.0 CONCLUSIONS AND RECOMMENDATIONS
  • 6.1 Conclusions
  • 6.2 Recommendations
• Annexes
  • Annex A – Steering Committee
  • Annex B – Evaluation Matrix
  • Annex C – Logic Model
  • Annex D – Listing of Documents Reviewed
  • Annex E – Interview Guides
  • Annex F – Steering Committee Focus Group Summary
  • Annex G – Analysis of Achievement of Activities and Outputs
  • Annex H – Analysis of Achievement of Outcomes
• Footnotes